Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The British Journal of Radiology|March 7, 2000
The risks of treating keloids with radiotherapyN Botwood, C Lewanski, C Lowdell
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 4, 1999
Bilateral cerebellopontine metastases in a patient with an unknown primaryC R Lewanski, N Botwood, M G Glaser
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancerN Botwood, R James, C Vernon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I studyR D James, N Botwood, C C Vernon, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Sex hormone-binding globulin and female reproductive functionN Botwood, D Hamilton-Fairley, D Kiddy, et al.
Pharmacoeconomics|May 8, 2002
Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancerM Lees, M Aristides, N Maniadakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2007
Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II studyI Chau, D Cunningham, T Hickish, et al.
BJU International|July 31, 2003
Squamous cell carcinoma antigen: a role in the early identification of nodal metastases in men with squamous cell carcinoma of the penisM E Laniado, C Lowdell, H Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2008
Treatment of primary rectal squamous cell carcinoma by primary chemoradiotherapy: should surgery still be considered a standard of care?J Clark, S Cleator, R Goldin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
A pilot study to evaluate paclitaxel (Taxol) as primary medical treatment for patients with inoperable stage III and IV breast carcinomaC N Rees, D Sinnett, C Lowdell, et al.
Pageof 2